Company profile for Nested Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are Nested Therapeutics, a biotech company inspired by service and driven by a desire to make a meaningful impact. We are creative innovators who challenge our own assumptions as we strive to find new, overlooked areas of opportunity to design therapeutics for a perfect fit. We embrace diverse perspectives and experiences in a space for everyone to add value and be valued in return, with the purpose of building solutions to...
We are Nested Therapeutics, a biotech company inspired by service and driven by a desire to make a meaningful impact. We are creative innovators who challenge our own assumptions as we strive to find new, overlooked areas of opportunity to design therapeutics for a perfect fit. We embrace diverse perspectives and experiences in a space for everyone to add value and be valued in return, with the purpose of building solutions together while having fun doing it. United through our common vision for the future of precision medicine and our shared values of service, humility, impact, invention, and connection.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Cambridge, MA
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/nested-therapeutics-announces-oral-presentation-of-preclinical-data-for-nst-628-a-novel-fully-brain-penetrant-pan-rafmek-molecular-glue-at-the-2024-aacr-annual-meeting-302110793.html

PR NEWSWIRE
08 Apr 2024

https://www.prnewswire.com/news-releases/nested-therapeutics-to-present-preclinical-data-for-nst-628-a-novel-pan-rafmek-molecular-glue-in-the-new-drugs-on-the-horizon-series-at-2024-aacr-annual-meeting-302101828.html

PR NEWSWIRE
28 Mar 2024

https://www.prnewswire.com/news-releases/nested-therapeutics-announces-fda-clearance-of-investigational-new-drug-ind-application-for-nst-628-a-novel-pan-rafmek-molecular-glue-302101827.html

PR NEWSWIRE
28 Mar 2024

https://www.prnewswire.com/news-releases/nested-therapeutics-presents-first-preclinical-data-for-lead-candidate-nst-628-a-rasmapk-pathway-inhibitor-at-2023-aacr-nci-eortc-conference-301953990.html

PR NEWSWIRE
12 Oct 2023

https://www.prnewswire.com/news-releases/nested-therapeutics-to-present-preclinical-data-for-novel-potential-best-in-class-inhibitor-of-the-rasmapk-pathway-at-2023-aacr-nci-eortc-conference-301947339.html

PR NEWSWIRE
04 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty